A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers
Not Applicable
Completed
- Conditions
- Tobacco Use DisorderHead and Neck NeoplasmsRadiationThoracic Neoplasms
- Registration Number
- NCT02188563
- Brief Summary
Smoking is the greatest risk factor for upper aerodigestive cancers (thoracic or head and neck) and negatively impacts survival and other outcomes, but many patients have difficulty quitting after their diagnosis. Smoking cessation interventions for cancer patients thus far have had limited success. This is a pilot randomized controlled trial designed to determine if a new comprehensive, evidence-based smoking cessation intervention can improve quit rates for cancer patients who smoke.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- New diagnosis of head and neck or thoracic (including lung) cancer
- Undergoing radiation at Johns Hopkins Radiation Oncology for 5 or more weeks
- English-speaking and able to provide informed consent
- Smoked any cigarettes in previous 14 days
Exclusion Criteria
- Palliative radiation
- Undergoing stereotactic radiosurgery
- Pregnant or breastfeeding
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Smoking cessation 8 weeks Smoking cessation will be defined as BOTH (1) self-reported 7-day abstinence from smoking and (2) exhaled carbon monoxide level of 8 or lower as biochemical confirmation of abstinence.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Johns Hopkins Medicine
🇺🇸Baltimore, Maryland, United States
Johns Hopkins Medicine🇺🇸Baltimore, Maryland, United States